Alm Pharma
Key points
€6,000 100 shares
No accounts filed yet
Signals
Recent changes
Incorporation
Founding capital of €6,000, 100 shares · Founder: · Appointment: (director) · published on 29-10-2026 · Gazette deed
Official details
Source: KBO- Status
- Active since 27-10-2026Normal situation
- Activity
- “Apothekersactiviteiten en farmaceutische zorg” (deed in Dutch)From the articles, 6 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on Alm Pharma
Alm Pharma is less than twelve months old. There is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals.
No annual accounts have been filed with the National Bank.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Key facts about Alm Pharma
- What is the company number of Alm Pharma?
- The company number of Alm Pharma is 1044.553.903. The VAT number is the same number with BE in front: BE 1044.553.903.
- Where is Alm Pharma based?
- The registered office is at Deurnsebaan 45, 2170 Antwerp.Company details
- What is the legal form of Alm Pharma?
- Alm Pharma is a private limited company (BV).
- When was Alm Pharma founded?
- Alm Pharma was founded on 27-10-2026.
- Is Alm Pharma still active?
- Yes, Alm Pharma is an active enterprise in the KBO register.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See who is behind this young company and which other companies they have.Network investigator Check whether the registered address is a letterbox address or a business centre.Addresses
See how customers, suppliers and banks see your own company and what to improve first.